Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0019 | 1 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |